QT Medical
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
QT Medical is currently valued at N/A as of March 18, 2025. The company has raised a total of $19.4M in funding.
Investment Perspective
QT Medical's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is QT Medical Worth in 2025?
As of 2025, QT Medical is valued at N/A, based on the company's Accelerator/Incubator funding round in March 18, 2025. This valuation positions QT Medical as one of the leading private companies in the sector.
QT Medical Valuation History
QT Medical's funding history demonstrates steady growth and investor confidence.
How QT Medical Valuation is Determined
Private company valuations like QT Medical's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
QT Medical Valuation FAQs
Is QT Medical profitable?
QT Medical has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does QT Medical's valuation compare to competitors?
QT Medical is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will QT Medical IPO?
QT Medical has not announced plans for an initial public offering. Until an IPO, investors can access QT Medical shares through secondary market platforms.